Moreover, these findings foster the hypothesis of diabetes-induced initiation and progression of CAVD and further suggest that the involved molecular events may be only partly mediated by mTOR signaling. The gene discussed is MTOR; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.